After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. After-hours trades for Vera Therapeutics Inc. (VERA) shows that investor sentiment remained same, with the stock’s consolidated last price remained same to $18.72. The Vera Therapeutics Inc. has recorded 311,612 volume in the after hours trading session. The stock was recently discussed on Yahoo Finance as it revealed that Vera Therapeutics Scheduled to Present at September Investor Conferences.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
Stocks Info
As a NASDAQ listed company, VERA falls under the Healthcare sector while operating within the Biotechnology industry segment. At the end of the last regular session, the stock closed at $18.72 and fluctuated between $18.74 as its day high and $18.32 as its day low. The current market capitalization of Vera Therapeutics Inc. is $791.67M. A total of 0.3 million shares were traded on the day, compared to an average of 715.32K shares.
Insider Activity
Aside from predicting where a stock will go, investors also consider insider trades as an indicator of the stock’s future direction. During the recent three months, VERA has seen 3 BUY and 0 SELL insider trades, representing the acquisition of 463,217 and the disposition of 0 shares. Over the last 12 months, there were 60 BUYs and 35 SELLs from insiders. Insiders purchased 5,024,714 shares during that period but sold 158,882.
In the most recent transaction, Fordyce Marshall sold 5,210 shares of VERA for 16.66 per share on Aug 21. After the transaction, the President and CEO now owns 243,361 company shares. In a previous transaction on Aug 21, Curley Joanne sold 1,490 shares at 16.66 per share. VERA shares that Chief Development Officer owns now total 26,962.
Among the insiders who sold shares, Lin Celia disposed of 1,490 shares on Aug 21 at a per-share price of $16.65. This resulted in the Chief Medical Officer holding 11,010 shares of VERA after the transaction. In another insider transaction, Grant Sean bought 5,000 shares at $16.60 per share on Jun 23. Company shares held by the Chief Financial Officer now total 5,992.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. According to analysts who have offered 12-month price targets for VERA in the last 3 months, the mean price target is $19.17 with high estimates of $27.00 and low estimates of $10.00. In terms of 52-week highs and lows, VERA has a high of $23.39 and a low of $5.20.
As of this writing, VERA has an earnings estimate of -$0.55 per share for the current quarter. EPS was calculated based on a consensus of 5 estimates, with a high estimate of -$0.5 per share and a lower estimate of -$0.7. The company reported an EPS of -$0.8 in the last quarter, which was -33.30% lower than expectations of -$0.6.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. VERA’s latest balance sheet shows that the firm has $79.67M in Cash & Short Term Investments as of fiscal 2021. There were $4.92M in debt and $7.69M in liabilities at the time. Its Book Value Per Share was $3.17, while its Total Shareholder’s Equity was $69.59M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for VERA is Buy with a score of 4.43.
